USD 20.63 billion
Microfluidics Market Size, Share, Growth Analysis, By Product(Microfluidics-based Device, Microfluidic Components [Microfluidic Chip, Flow and Pressure Sensors, Flow and Pressure Controllers), By Material(Glass, Silicon, Polymer, Others), By Application(In Vitro Diagnostics [Clinical Diagnostics, Point of Care Testing, Veterinary Diagnostics], Pharmaceutical & Life Science Research and Manufacturing [Lab Analytics (Proteomic analysis), By End-user(Hospital and Diagnostic Centers, Academic and Research Institute, Pharmaceutical & Biotechnology Companies), By Region - Industry Forecast 2024-2031
Report ID:
SQMIG35A2288 |
Region:
Global |
Published Date: September, 2024
Pages:
219
|Tables:
63
|Figures:
77
Microfluidics Market Insights
Global Microfluidics Market size was valued at USD 21.70 billion in 2022 and is poised to grow from USD 24.48 billion in 2023 to USD 64.16 billion by 2031, growing at a CAGR of 12.8% during the forecast period (2024-2031).
The physical and chemical characteristics of liquids and gases at the microscale are utilized by microfluidic devices. Compared to systems of a traditional size, microfluidic devices provide a number of advantages. As microfluidics makes it possible to analyse and use less volumes of samples, chemicals, and reagents, application costs are lower overall. Microfluidic systems find extensive application in processes like capillary electrophoresis, isoelectric focusing, immunoassays, flow cytometry, mass spectrometry sample injection, PCR amplification, DNA analysis, cell manipulation and separation, and cell patterning. The rise in the market for microfluidic devices is fuelled by the rising incidence of chronic and infectious diseases.
The purpose of the microfluidic devices is illness screening. Microfluidic devices are also employed in the early detection of cancer. Moreover, the industry is growing due to the growing number of elderly people. The market is rising as manufacturers and developers are becoming more and more interested in creating microfluidic devices. The joint efforts of manufacturers to establish a presence in new markets also aid in the expansion of the industry. One example is a request for manufacturing initiatives that require finance, launched by uFluidix, a leader in the bespoke manufacture of microfluidic devices composed of thermoplastics and PDMS. After effectively tripling their production capacity in the past 12 months, the uFluidix team is currently adjusting for novel process factors in the thermoplastic microfluidic chip manufacturing process.
US Microfluidics Market is poised to grow at a sustainable CAGR for the next forecast period.
Market Snapshot - 2024-2031
Global Market Size
Largest Segment
Medical
Fastest Growth
Medical
Growth Rate
12.22% CAGR
Global Microfluidics Market ($ Bn)
Country Share by North America (%)
To get more reports on the above market click here to Buy The Report
Microfluidics Market Segmental Analysis
Global Microfluidics Market is segmented by Product, Material, application, end user and region. Based on Product, the market is segmented into Microfluidics-based Device, Microfluidic Components. Based on Material, the market is segmented into Glass, Silicon, Polymer, and Others. Based on Application, the market is segmented into In Vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing, Therapeutics. Based on End User, the market is segmented into Hospital and Diagnostic Centers, Academic and Research Institute, Pharmaceutical & Biotechnology Companies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.
Microfluidics Market Analysis by Product
As per categorization by product, the market is classified as microfluidic-based devices and microfluidic components. Among these, small molecules earned the largest share and continue to dominate the market. Microfluidic elements are the propelling forces of the global microfluidics market with innovations in diagnostics, drug delivery systems, and lab on a chip technology. Their small size, accurate control of the movement of fluids, and conjunction with biosensors render them critical to biotech and pharmaceutical industries. Microfluidic components account for a large segment of the market since they promote improved analytical efficacy, diminished sample sizes, and faster readily available diagnosis for point of care testing that seeks to meet the consumers large appetite for efficacious and efficient medical care systems.
It is anticipated that micro fluidic devices will be the fastest-growing devices segment in the overall microfluidics market owing to those devices which have revolutionized diagnostics, healthcare and the process of drug discovery. The functions of these devices include high-throughput screening, fast analysis, and accurate management of small amounts of liquid media, which are especially important for such tasks as point-of-care-testing, and personalized medicine lab-on-chip systems. Their scalability, integration with digital health platforms, and cost-effectiveness are driving adoption across clinical and research settings. As healthcare increasingly shifts toward decentralized, portable solutions, microfluidic-based devices offer a powerful tool for improving diagnostic accuracy and treatment efficiency, fueling their rapid growth in the market.
Microfluidics Market Analysis by Application
In the global microfluidics market, in-vitro diagnostics (IVD) are promoting innovation because they can deliver quick, precise, and high-volume analyses effectively. Microfluidic technologies are incorporated in IVD platforms which allow lower sensitivity to generic drugs, low volume consumption of reagents, and processing of a smaller sample size which is important for disease diagnostic and tailored health interventions. The market has been largely dominated by the in-vitro diagnostics (IVD) segment due to its importance in point-of-care testing, where patients receive test results in the shortest time possible and with minimal involvement of the user. Besides microfluidics incorporated in IVD systems has improved clinical workflows by increasing the speed, accuracy, and scalability of the diagnosis. Thus, meeting the needs of the emerging healthcare market.
Owing to the growing requirement of more efficient drug architecture, development, and testing processes, it is expected that pharmaceutical and life science research and manufacturing will be the most growing sectors in the global microfluidics market. The technologies based on microfluidics allow for miniaturization and automation and therefore high throughput screening with effective experimental control and analyses conducted in real time. Their ability to mimic physiological conditions makes them invaluable for developing personalized medicines and complex biological assays. As pharmaceutical companies and research institutions push for faster, cost-effective solutions, microfluidics offers improved accuracy, reduced reagent costs, and faster experimental cycles, driving its rapid adoption in life sciences and pharmaceutical manufacturing.
Global Microfluidics Market By Product (%)
To get detailed analysis on other segments, Request For Free Sample Report
Microfluidics Market Regional Insights
The global microfluidics market has its highest share in North America which can be explained by the developed health care system and the high investments in research and development with a larger number of the world’s pharmaceutical and biotechnology companies located therein. The demand for microfluidic devices in the region is heightened by the innovations in diagnostic technologies, personalized healthcare and lab-on-chip technologies. Favorable regulatory frameworks and strong government support for advanced medical research, particularly in the U.S., also contribute to the market's growth. Fueled by high incidences of chronic illnesses as well as the requirements for inexpensive and efficient diagnostic solutions tends to push North America to the front line where microfluidic techniques are being used across various healthcare and life sciences disciplines.
The global microfluidics market’s growth is greatly propelled by the Asia – Pacific region, which is mainly attributed to rising healthcare investments, technological innovations, and the swiftly rising personalized medicine approach. The growth of the macroeconomics of China, Japan, India, and growth in pharmaceutical and biotechnology applications are factors driving the region’s market expansion along with the growing need for low-cost diagnostic methods and point of care testing. Government initiatives supporting healthcare innovation, coupled with an increasing prevalence of chronic diseases, further boost microfluidic adoption. Additionally, the region's strong manufacturing capabilities and growing research activities in lab-on-a-chip technologies make Asia Pacific a crucial player in the global microfluidics market expansion.
Global Microfluidics Market By Geography
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Microfluidics Market Dynamics
Microfluidics Market Drivers
Technological Advancements in Diagnostics and Drug Delivery
- The global microfluidics market is highly driven by advancements in microfluidic technologies like lab-on-a-chip devices and organ-on-chip systems. These developments allow faster and accurate diagnostics and efficient drug distribution which is essential in personalized medicine, point-of-care testing, and pharmaceutical research, thus enhancing the growth of the market.
Rising Demand for Cost-effective Healthcare Solutions
- An increasing demand for economic and effective healthcare services is one of the key factors fueling the growth of the global microfluidics market. There is a notable decrease in the costs involved in diagnosis and treatment due to the small number of samples required per test, and a high degree of automation of processes that microfluidic devices make possible. This need is acute in developing countries, which further boosts the growth of the market.
Restraints
Limited Awareness and Adoption in Emerging Markets
- A key restraint for the global microfluidics market is limited awareness and adoption in emerging markets. Most of the healthcare providers in developing countries do not understand the benefits and the application of microfluidic technologies, which leads to prolonged integration and low demand for these new diagnostic and treatment options.
Challenges in Integration with Existing Systems
- Furthermore, another limitation is in the difficulty of integrating microfluidic devices with any existing laboratory or clinical systems. Current diagnostic devices, analytic machines, and infrastructure all seem incompatible and require more modern enhancements in techniques and finances which discourage organizations and health providers from embracing microfluidics.
Request Free Customization of this report to help us to meet your business objectives.
Microfluidics Market Competitive Landscape
The global microfluidics market is made up of various players combining old players and new player startups that focus on new technologies. The major international companies include Thermo Fisher Scientific, Agilent Technologies, Roche that have state-of-the-art microfluidics technologies. Other companies include Bio-Rad Laboratories, and Fluidigm among other players. New players enter the market with better performing products which increases competition and improves the products in the market and widens the applications in health diagnostics, drug dispensing and research in life sciences.
Microfluidics Market Top Player’s Company Profiles
- Thermo Fisher Scientific (US)
- Becton, Dickinson, and Company (US)
- Agilent Technologies (US)
- Bio-Rad Laboratories (US)
- F. Hoffmann-La Roche (Switzerland)
- Danaher Corporation (US)
- Illumina Inc. (US)
- Fluidigm Corporation (US)
- Abbott Laboratories (US)
- BioMérieux (France)
- Hologic (US)
- Quidel Corporation (US)
- SMC Corporation (Japan)
- Parker-Hannifin Corporation (US)
- IDEX Corporation (US)
- Fortive Corporation (US)
- Aignep S.p.A (Italy)
- Dolomite Microfluidics (UK)
- Elveflow (France)
- uFluidix (Canada)
- NanoString Technologies (US)
- Nortis Inc. (US)
- Innovative Biochips, LLC (US)
- Fluidic Analytics (UK)
Microfluidics Market Recent Developments
- In August 2023, Agilent Technologies presented its newer microfluidics-based cancer detection gadget which is intended to make the process of biomarker detection easier for cancer research. The equipment employs advanced microfluidics chip technology that enables the multitasking of analyzing different samples at the same time. The improvement is expected to speed up cancer diagnosis and also improve cancer research.
- In July 2023, Fluidigm Corporation has revealed that it has entered into a partnership with one of the biopharmaceutical companies towards the development of microfluidic solutions for drug discovery. The focus of this collaboration and integration is on high-throughput screening workflows and the microfluidic technology of Fluidigm, to optimize the drug development process and allow for precision medicine.
- In September 2023, Thermo Fisher Scientific launched a new microfluidic platform which can perform genomic assays in a high throughput mode. This new system combines the power of next-generation sequencing with advanced microfluidic technologies thus making genetic tests more reliable and efficient. The said advancement is aimed at enhancing the practice of individualized medicine and thus bettering patient care.
Microfluidics Key Market Trends
- Growing Demand for Point-of-Care Testing Solutions: The global microfluidics market is experiencing a remarkable shift in focus towards the POC testing (point of care testing) solutions - the rapid and accurate diagnostics. This transformation allows improving patient access to timely care, especially in rural regions, and facilitates the growing use of microfluidic devices in emergency and domiciliary care.
- Integration of Microfluidics with AI and Automation: Another prominent development is the movement of microfluidic systems toward artificial intelligence (AI) and automation. This trifecta improves data management, refines the precision of diagnostic tests, and optimizes processes within labs and clinics, thus, enabling breakthroughs in drug development, tailoring of treatments to individual patients, and improving overall organizational aspects of healthcare.
Microfluidics Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, in conclusion, the global microfluidics market is experiencing rapid growth driven by technological advancements, increasing demand for efficient healthcare solutions, and rising chronic disease incidences. The versatility of microfluidic devices enhances diagnostic accuracy and reduces costs, making them essential in personalized medicine and drug delivery.
North America and the Asia Pacific is one of the regions which is a major contributor and encourages innovations by investing in research and development. However, certain challenges such as low levels of awareness in developing nations and issues with integration persist. Due to ongoing investments, the market will experience further shifts owing to the integration of m,’ across all sectors and cooperation with all stakeholders, thereby revolutionizing the diagnosis and treatment of diseases.
| Report Metric | Details |
|---|---|
| Market size value in 2022 | USD 21.70 billion |
| Market size value in 2031 | USD 64.16 billion |
| Growth Rate | 12.8% |
| Base year | 2023 |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Microfluidics Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Microfluidics Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Microfluidics Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Microfluidics Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Microfluidics Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Microfluidics Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
